Search Results

You are looking at 1 - 10 of 33 items for :

  • hormone therapy x
Clear All
Trine Holm Johannsen Department of Growth and Reproduction, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Trine Holm Johannsen in
Google Scholar
PubMed
Close
,
Jakob Albrethsen Department of Growth and Reproduction, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Jakob Albrethsen in
Google Scholar
PubMed
Close
,
Vassos Neocleous The Cyprus Institute of Neurology and Genetics, Department of Molecular Genetics, Function and Therapy, Nicosia, Cyprus

Search for other papers by Vassos Neocleous in
Google Scholar
PubMed
Close
,
Federico Baronio S. Orsola-Malpighi University Hospital, Department of Medical and Surgical Sciences, Bologna, Italy

Search for other papers by Federico Baronio in
Google Scholar
PubMed
Close
,
Martine Cools Department of Pediatrics, Division of Pediatric Endocrinology, Ghent University Hospital and Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium

Search for other papers by Martine Cools in
Google Scholar
PubMed
Close
,
Lise Aksglaede Department of Growth and Reproduction, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Lise Aksglaede in
Google Scholar
PubMed
Close
,
Niels Jørgensen Department of Growth and Reproduction, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Niels Jørgensen in
Google Scholar
PubMed
Close
,
Peter Christiansen Department of Growth and Reproduction, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Peter Christiansen in
Google Scholar
PubMed
Close
,
Meropi Toumba The Cyprus Institute of Neurology and Genetics, Department of Molecular Genetics, Function and Therapy, Nicosia, Cyprus
Pediatric Endocrinology Clinic, Department of Pediatrics, Aretaeio Hospital, Nicosia, Cyprus

Search for other papers by Meropi Toumba in
Google Scholar
PubMed
Close
,
Pavlos Fanis The Cyprus Institute of Neurology and Genetics, Department of Molecular Genetics, Function and Therapy, Nicosia, Cyprus

Search for other papers by Pavlos Fanis in
Google Scholar
PubMed
Close
,
Marie Lindhardt Ljubicic Department of Growth and Reproduction, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Marie Lindhardt Ljubicic in
Google Scholar
PubMed
Close
, and
Anders Juul Department of Growth and Reproduction, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
Department of Clinical Medicine, University of Copenhagen, Denmark

Search for other papers by Anders Juul in
Google Scholar
PubMed
Close

adrenocorticotropic hormone and, thus, an overproduction of adrenal androgens, which may result in virilization, an altered growth pattern, and infertility ( 2 ). Treatment of CAH may comprise life-long replacement therapy with glucocorticoids and mineralocorticoids

Open access
Magdalena Lech Faculty of Life Sciences and Medicine, School of Life Course Sciences, King’s College London, London, UK

Search for other papers by Magdalena Lech in
Google Scholar
PubMed
Close
,
Ruvini Ranasinghe Department of Clinical Biochemistry, King’s College Hospital NHS Foundation Trust, Denmark Hill, London, UK

Search for other papers by Ruvini Ranasinghe in
Google Scholar
PubMed
Close
,
Royce P Vincent Department of Clinical Biochemistry, King’s College Hospital NHS Foundation Trust, Denmark Hill, London, UK
Faculty of Life Sciences and Medicine, School of Life Course Sciences, King’s College London, London, UK

Search for other papers by Royce P Vincent in
Google Scholar
PubMed
Close
,
David R Taylor Department of Clinical Biochemistry, King’s College Hospital NHS Foundation Trust, Denmark Hill, London, UK

Search for other papers by David R Taylor in
Google Scholar
PubMed
Close
,
Lea Ghataore Department of Clinical Biochemistry, King’s College Hospital NHS Foundation Trust, Denmark Hill, London, UK

Search for other papers by Lea Ghataore in
Google Scholar
PubMed
Close
,
James Luxton Department of Clinical Biochemistry, King’s College Hospital NHS Foundation Trust, Denmark Hill, London, UK

Search for other papers by James Luxton in
Google Scholar
PubMed
Close
,
Fannie Lajeunesse-Trempe Department of Endocrinology ASO/EASO COM, King's College Hospital NHS Foundation Trust, Denmark Hill, London, UK
Quebec Heart and Lung Institute, Laval University, Quebec, Canada

Search for other papers by Fannie Lajeunesse-Trempe in
Google Scholar
PubMed
Close
,
Pia Roser Department of Endocrinology and Diabetes, University Medical Centre Hamburg Eppendorf, Hamburg, Germany

Search for other papers by Pia Roser in
Google Scholar
PubMed
Close
,
Eftychia E Drakou Department of Clinical Oncology, Guy's Cancer Centre - Guy's and St Thomas' NHS Foundation Trust, Great Maze Pond, London, UK

Search for other papers by Eftychia E Drakou in
Google Scholar
PubMed
Close
,
Ling Ling Chuah Department of Endocrinology ASO/EASO COM, King's College Hospital NHS Foundation Trust, Denmark Hill, London, UK

Search for other papers by Ling Ling Chuah in
Google Scholar
PubMed
Close
,
Ashley B Grossman Green Templeton College, University of Oxford, Oxford, UK
Barts and the London School of Medicine, Centre for Endocrinology, William Harvey Institute, London, UK
Neuroendocrine Tumour Unit, Royal Free Hospital, London, UK

Search for other papers by Ashley B Grossman in
Google Scholar
PubMed
Close
,
Simon J B Aylwin Department of Endocrinology ASO/EASO COM, King's College Hospital NHS Foundation Trust, Denmark Hill, London, UK

Search for other papers by Simon J B Aylwin in
Google Scholar
PubMed
Close
, and
Georgios K Dimitriadis Department of Endocrinology ASO/EASO COM, King's College Hospital NHS Foundation Trust, Denmark Hill, London, UK
Obesity, Type 2 Diabetes and Immunometabolism Research Group, School of Cardiovascular and Metabolic Medicine & Sciences, Faculty of Life Course Sciences, King’s College London, London, UK
Division of Reproductive Health, Warwick Medical School, University of Warwick, Coventry, UK

Search for other papers by Georgios K Dimitriadis in
Google Scholar
PubMed
Close

mitotane therapy frequently being offered glucocorticoid replacement therapy ( 2 ). Whilst the existing literature quite clearly demonstrates the impact of mitotane on steroids and hormone-binding proteins, to date, no studies have specifically related

Open access
Deirdre Green Academic Department of Endocrinology, Beaumont Hospital and the Royal College of Surgeons in Ireland, Dublin

Search for other papers by Deirdre Green in
Google Scholar
PubMed
Close
,
Rosemary Dineen Academic Department of Endocrinology, Beaumont Hospital and the Royal College of Surgeons in Ireland, Dublin

Search for other papers by Rosemary Dineen in
Google Scholar
PubMed
Close
,
Michael W O’Reilly Academic Department of Endocrinology, Beaumont Hospital and the Royal College of Surgeons in Ireland, Dublin

Search for other papers by Michael W O’Reilly in
Google Scholar
PubMed
Close
, and
Mark Sherlock Academic Department of Endocrinology, Beaumont Hospital and the Royal College of Surgeons in Ireland, Dublin

Search for other papers by Mark Sherlock in
Google Scholar
PubMed
Close

, modified-release hydrocortisone preparations have been developed and investigated as GC replacement therapy in patients with CAH ( 78 , 79 ). A recent phase III trial including 122 patients with classic CAH revealed superior hormonal control using modified

Open access
Rachel Forfar Centre for Therapeutics Discovery, LifeArc, Accelerator Building, Open Innovation Campus, Stevenage, UK

Search for other papers by Rachel Forfar in
Google Scholar
PubMed
Close
,
Mashal Hussain Centre for Endocrinology, William Harvey Research Institute, Queen Mary University of London, London, UK

Search for other papers by Mashal Hussain in
Google Scholar
PubMed
Close
,
Puneet Khurana Centre for Therapeutics Discovery, LifeArc, Accelerator Building, Open Innovation Campus, Stevenage, UK

Search for other papers by Puneet Khurana in
Google Scholar
PubMed
Close
,
Jennifer Cook Centre for Therapeutics Discovery, LifeArc, Accelerator Building, Open Innovation Campus, Stevenage, UK

Search for other papers by Jennifer Cook in
Google Scholar
PubMed
Close
,
Steve Lewis Centre for Therapeutics Discovery, LifeArc, Accelerator Building, Open Innovation Campus, Stevenage, UK

Search for other papers by Steve Lewis in
Google Scholar
PubMed
Close
,
Dillon Popat Centre for Endocrinology, William Harvey Research Institute, Queen Mary University of London, London, UK

Search for other papers by Dillon Popat in
Google Scholar
PubMed
Close
,
David Jackson Centre for Endocrinology, William Harvey Research Institute, Queen Mary University of London, London, UK

Search for other papers by David Jackson in
Google Scholar
PubMed
Close
,
Ed McIver Centre for Therapeutics Discovery, LifeArc, Accelerator Building, Open Innovation Campus, Stevenage, UK

Search for other papers by Ed McIver in
Google Scholar
PubMed
Close
,
Jeff Jerman Centre for Therapeutics Discovery, LifeArc, Accelerator Building, Open Innovation Campus, Stevenage, UK

Search for other papers by Jeff Jerman in
Google Scholar
PubMed
Close
,
Debra Taylor Centre for Therapeutics Discovery, LifeArc, Accelerator Building, Open Innovation Campus, Stevenage, UK

Search for other papers by Debra Taylor in
Google Scholar
PubMed
Close
,
Adrian JL Clark Centre for Endocrinology, William Harvey Research Institute, Queen Mary University of London, London, UK

Search for other papers by Adrian JL Clark in
Google Scholar
PubMed
Close
, and
Li F Chan Centre for Endocrinology, William Harvey Research Institute, Queen Mary University of London, London, UK

Search for other papers by Li F Chan in
Google Scholar
PubMed
Close

Introduction The melanocortins, comprising the α-, β-, and γ-melanocyte-stimulating hormones (MSHs) and adrenocorticotropic hormone (ACTH), are a family of peptide hormones cleaved from the prohormone pro-opiomelanocortin that have a diverse

Open access
Ditte Sofie Dahl Sørensen Department of Endocrinology and Metabolism, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Ditte Sofie Dahl Sørensen in
Google Scholar
PubMed
Close
,
Jesper Krogh Department of Endocrinology and Metabolism, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Jesper Krogh in
Google Scholar
PubMed
Close
,
Åse Krogh Rasmussen Department of Endocrinology and Metabolism, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Åse Krogh Rasmussen in
Google Scholar
PubMed
Close
, and
Mikkel Andreassen Department of Endocrinology and Metabolism, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Mikkel Andreassen in
Google Scholar
PubMed
Close

-hydroxyprogesterone in the upper normal to mildly elevated normal range as a treatment goal ( 3 ), but currently, there is no consensus in relation to optimal disease markers or timing between replacement therapy and assessment of hormone levels. In the guideline by

Open access
Paul-Martin Holterhus Department of Pediatrics I, Pediatric Endocrinology and Diabetology, University Hospital of Schleswig-Holstein, UKSH, Campus Kiel and Christian Albrechts University, CAU, Kiel, Germany

Search for other papers by Paul-Martin Holterhus in
Google Scholar
PubMed
Close
,
Alexandra Kulle Department of Pediatrics I, Pediatric Endocrinology and Diabetology, University Hospital of Schleswig-Holstein, UKSH, Campus Kiel and Christian Albrechts University, CAU, Kiel, Germany

Search for other papers by Alexandra Kulle in
Google Scholar
PubMed
Close
,
Anne-Marie Till Department of Pediatrics, Pediatric Hematology and Oncology, University Hospital of Schleswig-Holstein, UKSH, Campus Lübeck, Germany

Search for other papers by Anne-Marie Till in
Google Scholar
PubMed
Close
,
Caroline Stille Department of Pediatrics, Pediatric Hematology and Oncology, University Hospital of Schleswig-Holstein, UKSH, Campus Lübeck, Germany

Search for other papers by Caroline Stille in
Google Scholar
PubMed
Close
,
Tabea Lamprecht Department of Pediatrics I, Pediatric Endocrinology and Diabetology, University Hospital of Schleswig-Holstein, UKSH, Campus Kiel and Christian Albrechts University, CAU, Kiel, Germany

Search for other papers by Tabea Lamprecht in
Google Scholar
PubMed
Close
,
Simon Vieth Department of Pediatrics I, Pediatric Hematology and Oncology, University Hospital of Schleswig-Holstein, UKSH, Campus Kiel and Christian-Albrechts-University, CAU, Kiel, Germany

Search for other papers by Simon Vieth in
Google Scholar
PubMed
Close
, and
Melchior Lauten Department of Pediatrics, Pediatric Hematology and Oncology, University Hospital of Schleswig-Holstein, UKSH, Campus Lübeck, Germany

Search for other papers by Melchior Lauten in
Google Scholar
PubMed
Close

more than 1 week, others reported durations ranging from 10 to 20 weeks and even up to several months after the end of the therapy ( 4 , 5 , 6 , 7 ). Inadequate function of the hypothalamic–pituitary–adrenal axis, and hence inadequate adrenal

Open access
Dafydd Aled Rees Cardiff University, Cardiff, United Kingdom

Search for other papers by Dafydd Aled Rees in
Google Scholar
PubMed
Close
,
Deborah P Merke National Institutes of Health Clinical Center and the Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, USA

Search for other papers by Deborah P Merke in
Google Scholar
PubMed
Close
,
Wiebke Arlt MRC LMS, London, United Kingdom

Search for other papers by Wiebke Arlt in
Google Scholar
PubMed
Close
,
Aude Brac De La Perriere Hospices Civils de Lyon - GHE - Endocrinologie, Bron, France

Search for other papers by Aude Brac De La Perriere in
Google Scholar
PubMed
Close
,
Angelica Linden Hirschberg Karolinska Institute, Solna, Sweden

Search for other papers by Angelica Linden Hirschberg in
Google Scholar
PubMed
Close
,
Anders Juul Department of Growth and Reproduction, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark, and Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Anders Juul in
Google Scholar
PubMed
Close
,
John Newell-Price The University of Sheffield, Sheffield, United Kingdom

Search for other papers by John Newell-Price in
Google Scholar
PubMed
Close
,
Alessandro Prete University of Birmingham, Birmingham, United Kingdom

Search for other papers by Alessandro Prete in
Google Scholar
PubMed
Close
,
Nicole Reisch Endokrinologie, Nephrologie und weitere Sektionen - Medizinische Klinik und Poliklinik IV - Campus Innenstadt, München, Germany

Search for other papers by Nicole Reisch in
Google Scholar
PubMed
Close
,
Nike M Stikkelbroeck Radboud University Nijmegen, Nijmegen, Netherlands

Search for other papers by Nike M Stikkelbroeck in
Google Scholar
PubMed
Close
,
Philippe A Touraine University Hospitals Pitié Salpêtrière - Charles Foix, Paris, France

Search for other papers by Philippe A Touraine in
Google Scholar
PubMed
Close
,
Alex Lewis Neurocrine Biosciences Inc, London, United Kingdom

Search for other papers by Alex Lewis in
Google Scholar
PubMed
Close
,
John Porter Neurocrine Biosciences Inc, London, United Kingdom

Search for other papers by John Porter in
Google Scholar
PubMed
Close
,
Helen Coope Neurocrine Biosciences Inc, London, United Kingdom

Search for other papers by Helen Coope in
Google Scholar
PubMed
Close
, and
Richard J Ross The University of Sheffield, Sheffield, United Kingdom

Search for other papers by Richard J Ross in
Google Scholar
PubMed
Close

Introduction The control of congenital adrenal hyperplasia (CAH) is suboptimal on standard hydrocortisone replacement therapy because it does not control the overnight rise in adrenocorticotropic hormone (ACTH) that drives the production of

Open access
Jorge Gabriel Ruiz-Sánchez Servicio de Endocrinología y Nutrición. Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD, UAM), Hospital Universitario Fundación Jiménez Díaz, Madrid, España
Facultad de Medicina, Universidad Complutense de Madrid, Madrid, España

Search for other papers by Jorge Gabriel Ruiz-Sánchez in
Google Scholar
PubMed
Close
,
Alfonso Luis Calle-Pascual Facultad de Medicina, Universidad Complutense de Madrid, Madrid, España
Servicio de Endocrinología y Nutrición. Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Hospital Clínico San Carlos, Madrid, España
Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Madrid, España

Search for other papers by Alfonso Luis Calle-Pascual in
Google Scholar
PubMed
Close
,
Miguel Ángel Rubio-Herrera Facultad de Medicina, Universidad Complutense de Madrid, Madrid, España
Servicio de Endocrinología y Nutrición. Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Hospital Clínico San Carlos, Madrid, España

Search for other papers by Miguel Ángel Rubio-Herrera in
Google Scholar
PubMed
Close
,
María Paz De Miguel Novoa Facultad de Medicina, Universidad Complutense de Madrid, Madrid, España
Servicio de Endocrinología y Nutrición. Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Hospital Clínico San Carlos, Madrid, España

Search for other papers by María Paz De Miguel Novoa in
Google Scholar
PubMed
Close
,
Emilia Gómez-Hoyos Servicio de Endocrinología y Nutrición, Hospital Clínico Universitario de Valladolid, Valladolid, España

Search for other papers by Emilia Gómez-Hoyos in
Google Scholar
PubMed
Close
, and
Isabelle Runkle Facultad de Medicina, Universidad Complutense de Madrid, Madrid, España
Servicio de Endocrinología y Nutrición. Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Hospital Clínico San Carlos, Madrid, España

Search for other papers by Isabelle Runkle in
Google Scholar
PubMed
Close

resistance to mineralocorticoid action (such as trimethoprim therapy) coincide ( 6 ). Yet the same study of 112 episodes of hypoaldosteronism also revealed that euvolemic hyponatremia (EH) was present in 19/112 (16.9%) of episodes. The fact that the volemic

Open access
Wenhao Lin Department of Urology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Search for other papers by Wenhao Lin in
Google Scholar
PubMed
Close
,
Jun Dai Department of Urology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Search for other papers by Jun Dai in
Google Scholar
PubMed
Close
,
Jialing Xie Department of Pathology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Search for other papers by Jialing Xie in
Google Scholar
PubMed
Close
,
Jiacheng Liu Department of Urology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Search for other papers by Jiacheng Liu in
Google Scholar
PubMed
Close
,
Fukang Sun Department of Urology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Search for other papers by Fukang Sun in
Google Scholar
PubMed
Close
,
Xin Huang Department of Urology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Search for other papers by Xin Huang in
Google Scholar
PubMed
Close
,
Wei He Department of Urology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Search for other papers by Wei He in
Google Scholar
PubMed
Close
,
Chen Fang Department of Urology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Search for other papers by Chen Fang in
Google Scholar
PubMed
Close
,
Juping Zhao Department of Urology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Search for other papers by Juping Zhao in
Google Scholar
PubMed
Close
, and
Danfeng Xu Department of Urology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Search for other papers by Danfeng Xu in
Google Scholar
PubMed
Close

Introduction Adrenocortical carcinoma (ACC) is a rare and aggressive cancer that affects both children and adults, having an overall incidence of 1–2 cases/million per year. In most cases, cancer presents with steroid hormone excess ( 1

Open access
Arno Téblick Clinical Division and Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium

Search for other papers by Arno Téblick in
Google Scholar
PubMed
Close
,
Ilse Vanhorebeek Clinical Division and Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium

Search for other papers by Ilse Vanhorebeek in
Google Scholar
PubMed
Close
,
Inge Derese Clinical Division and Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium

Search for other papers by Inge Derese in
Google Scholar
PubMed
Close
,
An Jacobs Clinical Division and Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium

Search for other papers by An Jacobs in
Google Scholar
PubMed
Close
,
Renata Haghedooren Clinical Division and Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium

Search for other papers by Renata Haghedooren in
Google Scholar
PubMed
Close
,
Sofie Maebe Clinical Division and Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium

Search for other papers by Sofie Maebe in
Google Scholar
PubMed
Close
,
Gerdien A Zeilmaker-Roest Department of Neonatal & Pediatric Intensive Care, Division of Pediatric Intensive Care, Erasmus MC – Sophia Children’s Hospital, Rotterdam, the Netherlands

Search for other papers by Gerdien A Zeilmaker-Roest in
Google Scholar
PubMed
Close
,
Enno D Wildschut Department of Neonatal & Pediatric Intensive Care, Division of Pediatric Intensive Care, Erasmus MC – Sophia Children’s Hospital, Rotterdam, the Netherlands

Search for other papers by Enno D Wildschut in
Google Scholar
PubMed
Close
,
Lies Langouche Clinical Division and Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium

Search for other papers by Lies Langouche in
Google Scholar
PubMed
Close
, and
Greet Van den Berghe Clinical Division and Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium

Search for other papers by Greet Van den Berghe in
Google Scholar
PubMed
Close

of the ACTH precursor, pro-opiomelanocortin (POMC) ( 1 ). Results from our mechanistic animal study suggested that during sepsis-induced critical illness, preserved hypothalamic corticotropin-releasing hormone (CRH) and arginine vasopressin (AVP

Open access